Investors and Media

Press Releases

November 19, 2018

Scholar Rock Announces the Addition of Edward (Ted) Myles to Its Board of Directors

November 9, 2018

Scholar Rock Demonstrates that Highly Specific TGFβ1 Inhibition Combined with Anti-PD1 Drives Tumor Regression and Survival Benefit in Preclinical Models of Primary Resistance to Checkpoint Blockade Therapy

November 8, 2018

Scholar Rock Reports Third Quarter 2018 Financial Results and Highlights Business Progress

October 31, 2018

Scholar Rock to Present at the Jefferies 2018 London Healthcare Conference

October 1, 2018

Scholar Rock to Present Preclinical Data Highlighting the Role of TGFβ1 Inhibition in Overcoming Checkpoint Resistance at the SITC Annual Meeting

August 8, 2018

Scholar Rock Reports Second Quarter 2018 Financial Results and Updates on Business Progress

August 2, 2018

Scholar Rock to Participate in Upcoming Investor Conferences

June 4, 2018

Scholar Rock Announces Exercise in Full and Closing of Over-Allotment Option in Initial Public Offering

Archived Press Releases